SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer
Clinical trial NCT03645876 · TERMINATED
Trial details
- NCT number
- NCT03645876
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-08
- Primary completion
- 2019-04-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.